Abstract

Limited information is available about the current epidemic status of hepatitis B virus (HBV) in Guangdong province in South China, where hepatitis B is endemic. We sought to provide an up-to-date assessment of hepatitis B prevalence in a large population through a community-based study. A total of 169,211 local residents were recruited using the stratified cluster random sampling method from 2014 to 2015, and each participant’s information was collected using an interviewer-administered questionnaire. Accordingly, the prevalence of hepatitis B surface antigen (HBsAg) in the total population was 8.76%. HBsAg prevalence was lowest (0.29%) among children aged 0–12 years and highest (12.71%) among those aged 23–59 years. Moreover, the prevalence (8.82%) in males approximately equalled that (8.65%) in females (P > 0.05). Overall, vaccination was effective in preventing HBV infection, regardless of age. Among adults aged 23–59 years, male sex tended to keep the HBsAg persistence. However, reduced persistence for participants with occasional physical exercise and drinking was observed. For participants older than 59 years, a history of prior surgery placed people at high risk for infection. Although Guangdong has successfully decreased the HBsAg prevalence among children, it is urgent to expand vaccination to adults, and employ interventions to reduce the infection risk.

Highlights

  • Infection of the hepatitis B virus (HBV) remains a severe public health problem worldwide

  • According to a 1992 national serosurvey in China, the population’s hepatitis B prevalence was 9.75%, with 120 million Chinese as hepatitis B surface antigen (HBsAg) carriers, 20 million suffering from chronic hepatitis B, and approximately 300,000 deaths each year caused by HBV-related infections[2,3]

  • This study provided an up-to-date assessment of hepatitis B infection and relevant factors among community residents in the Pearl River Delta region during the period of 2014–2015

Read more

Summary

Introduction

Infection of the hepatitis B virus (HBV) remains a severe public health problem worldwide. According to a 1992 national serosurvey in China, the population’s hepatitis B prevalence was 9.75%, with 120 million Chinese as hepatitis B surface antigen (HBsAg) carriers, 20 million suffering from chronic hepatitis B, and approximately 300,000 deaths each year caused by HBV-related infections[2,3]. Liver cancer and cirrhosis have caused high mortality rates in China, and HBV infection is responsible for major deaths from these diseases[4]. In 1992, a nationwide hepatitis B routine immunization was recommended by China’s Ministry of Health, in which parents paid for both the vaccine and the user fee when having their infants vaccinated[6]. Studies have shown that relevant risk factors for most HBV infections in developed countries included sexual activity, injectable drug use, a family history of chronic hepatitis B, and occupational exposure[10,11,12]. There has been a potential shift in hepatitis B infection rates in recent years

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call